![Bill L. Nichols](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bill L. Nichols
Presidente presso
PROTAGENIC THERAPEUTICS, INC.
Profilo
William L.
Nichols is President at Protagenic Therapeutics, Inc. since 2026.
Mr. Nichols was Head-US Sales at Dova Pharmaceuticals, Inc. from 2018 to 2019.
Posizioni attive di Bill L. Nichols
| Società | Posizione | Inizio |
|---|---|---|
| PROTAGENIC THERAPEUTICS, INC. | Presidente | 03/02/2026 |
Precedenti posizioni note di Bill L. Nichols
| Società | Posizione | Fine |
|---|---|---|
| DOVA PHARMACEUTICALS, INC. | Vendite & Marketing | 01/01/2019 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
10
Relazioni di 1° grado
2
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Protagenic Therapeutics, Inc.
 Protagenic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that engages in discovery and development of therapeutics to treat stress-related neuropsychiatric & mood disorders | Health Technology |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
